Phosphodiesterase-5 inhibition suppresses colonic inflammation-induced tumorigenesis via blocking the recruitment of MDSC

American Journal of Cancer Research

Volumn 7, Issue 1, 2017, Pages 41-52

  Lin, Shiyong ^a,b   Wang, Jing ^a   Wang, Lihui ^a   Wen, Jing ^a   Guo, Yandong ^a   Qiao, Weiguang ^a   Zhou, Jieqiong ^a   Xu, Guoliang ^b   Zhi, Fachao ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Colitis; Colon cancer; MDSC; PDE 5; Sildenafil

Indexed keywords

PHOSPHODIESTERASE V; SILDENAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER PREVENTION; COLITIS; COLON CANCER; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; LEUKOCYTE MIGRATION; MALE; MOUSE; MYELOID-DERIVED SUPPRESSOR CELL; NONHUMAN; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 85009914916     PISSN: None     EISSN: 21566976     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Valencia T, Kim JY, Abu-Baker S, Moscat-Pardos J, Ahn CS, Reina-Campos M, Duran A, Castilla EA, Metallo CM, Diaz-Meco MT and Moscat J. Metabolic reprogramming of stro-mal fibroblasts through p62-mTORC1 signal-ing promotes inflammation and tumorigene-sis. Cancer Cell 2014; 26: 121-135.
2. Su S, Liu Q, Chen J, Chen J, Chen F, He C, Huang D, Wu W, Lin L, Huang W, Zhang J, Cui X, Zheng F, Li H, Yao H, Su F and Song E. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell 2014; 25: 605-620.
3. Hsu DS, Wang HJ, Tai SK, Chou CH, Hsieh CH, Chiu PH, Chen NJ and Yang MH. Acetylation of snail modulates the cytokinome of cancer cells to enhance the recruitment of macrophages. Cancer Cell 2014; 26: 534-548.
4. Gupta J, del Barco Barrantes I, Igea A, Sakellariou S, Pateras IS, Gorgoulis VG and Nebreda AR. Dual function of p38alpha MAPK in colon cancer: suppression of colitis-associated tumor initiation but requirement for cancer cell survival. Cancer Cell 2014; 25: 484-500.
5. Cooks T, Pateras IS, Tarcic O, Solomon H, Schetter AJ, Wilder S, Lozano G, Pikarsky E, Forshew T, Rosenfeld N, Harpaz N, Itzkowitz S, Harris CC, Rotter V, Gorgoulis VG and Oren M. Mutant p53 prolongs NF-kappaB acti-vation and promotes chronic inflammation and inflammation-associated colorectal cancer. Cancer Cell 2013; 23: 634-646.
6. Bonecchi R, Locati M and Mantovani A. Che-mokines and cancer: a fatal attraction. Cancer Cell 2011; 19: 434-435.
7. Bromberg J and Wang TC. Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell 2009; 15: 79-80.
8. Gillen CD, Walmsley RS, Prior P, Andrews HA and Allan RN. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994; 35: 1590-1592.
9. Satpathy SR, Jala VR, Bodduluri SR, Krishnan E, Hegde B, Hoyle GW, Fraig M, Luster AD and Haribabu B. Crystalline silica-induced leuko-triene B4-dependent inflammation promotes lung tumour growth. Nat Commun 2015; 6: 7064.
10. Arthur JC, Gharaibeh RZ, Muhlbauer M, Perez-Chanona E, Uronis JM, McCafferty J, Fodor AA and Jobin C. Microbial genomic analysis reveals the essential role of inflammation in bac-teria-induced colorectal cancer. Nat Commun 2014; 5: 4724.
11. Tinsley HN, Gary BD, Keeton AB, Zhang W, Abadi AH, Reynolds RC and Piazza GA. Sulindac sulfide selectively inhibits growth and indu-ces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G. Mol Cancer Ther 2009; 8: 3331-3340.
12. Li N, Xi Y, Tinsley HN, Gurpinar E, Gary BD, Zhu B, Li Y, Chen X, Keeton AB, Abadi AH, Moyer MP, Grizzle WE, Chang WC, Clapper ML and Piazza GA. Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/beta-catenin signaling. Mol Cancer Ther 2013; 12: 1848-1859.
13. Hoke NN, Salloum FN, Kass DA, Das A and Kukreja RC. Preconditioning by phosphodiesterase-5 inhibition improves therapeutic efficacy of adipose-derived stem cells follow-ing myocardial infarction in mice. Stem Cells 2012; 30: 326-335.
14. Fakhfouri G, Rahimian R, Hashemi S, Rasouli MR, Bahremand A, Mehr SE, Khorramizadeh MR and Dehpour AR. Sildenafil attenuates TNBS-induced colitis in rats: possible involvement of cGMP and KATP channels. Fundam Clin Pharmacol 2012; 26: 190-193.
15. Fan YF, Zhang R, Jiang X, Wen L, Wu DC, Liu D, Yuan P, Wang YL and Jing ZC. The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension. Cardiovasc Res 2013; 99: 395-403.
16. Garrido Abad P, Sinues Ojas B, Martinez Blazquez L, Conde Caturla P and Fernandez Arjona M. Safety and efficacy of intraurethral alprostadil in patients with erectile dysfunction refractory to treatment using phosphodiesterase-5 inhibitors. Actas Urol Esp 2015; 39: 635-640.
17. Bai Y and An R. Resveratrol and sildenafil synergistically improve diabetes-associated erectile dysfunction in streptozotocin-induced diabetic rats. Life Sci 2015; 135: 43-48.
18. Borlaug BA, Lewis GD, McNulty SE, Semigran MJ, LeWinter M, Chen H, Lin G, Deswal A, Margulies KB, Redfield MM. Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction. Circ Heart Fail 2015; 8: 533-541.
19. Margonis GA, Christoloukas N, Antoniou E, Arkadopoulos N, Theodoropoulos G, Agrogian-Nis G, Pikoulis E, Patsouris ES, Zografos GC and Papalois AE. Effectiveness of sildenafil and U-74389G in a rat model of colitis. J Surg Res 2015; 193: 667-674.
20. Iseri SO, Ersoy Y, Ercan F, Yuksel M, Atukeren P, Gumustas K and Alican I. The effect of sildenafil, a phosphodiesterase-5 inhibitor, on acetic acid-induced colonic inflammation in the rat. J Gastroenterol Hepatol 2009; 24: 1142-1148.
21. Aziret M, Irkorucu O, Reyhan E, Erdem H, Das K, Ozkara S, Surmelioglu A, Sozen S, Bali I, Cetinkunar S and Deger KC. The effects of vardenafil and pentoxifylline administration in an animal model of ischemic colitis. Clinics (Sao Paulo) 2014; 69: 763-769.
22. Reyhan E, Irkorucu O, Surmelioglu A, Ozkara S, Deger KC, Aziret M, Erdem H, Cetinkunar S, Demirturk P and Sehirli AO. Efficacy of pen-toxifylline and tadalafil in rat model of ische-mic colitis. J Invest Surg 2014; 27: 349-353.
23. Neufert C, Becker C and Neurath MF. An in-ducible mouse model of colon carcinogene-sis for the analysis of sporadic and inflam-mation-driven tumor progression. Nat Protoc 2007; 2: 1998-2004.
24. Weigmann B, Tubbe I, Seidel D, Nicolaev A, Becker C and Neurath MF. Isolation and sub-sequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat Protoc 2007; 2: 2307-2311.
25. Chen T, Yang M, Yu Z, Tang S, Wang C, Zhu X, Guo J, Li N, Zhang W, Hou J, Liu H, Han C, Liu Q, Gu Y, Qian C, Wan T, Cui L, Zhu M, Zheng W and Cao X. Small GTPase RBJ mediates nuclear entrapment of MEK1/MEK2 in tumor progression. Cancer Cell 2014; 25: 682-696.
26. Dai L, Cui X, Zhang X, Cheng L, Liu Y, Yang Y, Fan P, Wang Q, Lin Y, Zhang J, Li C, Mao Y, Wang Q, Su X, Zhang S, Peng Y, Yang H, Hu X, Yang J, Huang M, Xiang R, Yu D, Zhou Z, Wei Y and Deng H. SARI inhibits angiogenesis and tumour growth of human colon cancer through directly targeting ceruloplasmin. Nat Commun 2016; 7: 11996.
27. Zhu B, Vemavarapu L, Thompson WJ and Strada SJ. Suppression of cyclic GMP-specific phosphodiesterase 5 promotes apoptosis and inhibits growth in HT29 cells. J Cell Biochem 2005; 94: 336-350.
28. Whitt JD, Li N, Tinsley HN, Chen X, Zhang W, Li Y, Gary BD, Keeton AB, Xi Y, Abadi AH, Grizzle WE and Piazza GA. A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and beta-catenin transcriptional activity. Cancer Prev Res (Phila) 2012; 5: 822-833.
29. Califano JA, Khan Z, Noonan KA, Rudraraju L, Zhang Z, Wang H, Goodman S, Gourin CG, Ha PK, Fakhry C, Saunders J, Levine M, Tang M, Neuner G, Richmon JD, Blanco R, Agrawal N, Koch WM, Marur S, Weed DT, Serafini P and Borrello I. Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma. Clin Cancer Res 2015; 21: 30-38.
30. Gabrilovich DI and Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9: 162-174.
31. Li W, Zhang X, Chen Y, Xie Y, Liu J, Feng Q, Wang Y, Yuan W and Ma J. G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers. Protein Cell 2016; 7: 130-140.
32. Ostanin DV and Bhattacharya D. Myeloid-de-rived suppressor cells in the inflammatory bowel diseases. Inflamm Bowel Dis 2013; 19: 2468-2477.
33. Guan Q, Moreno S, Qing G, Weiss CR, Lu L, Bernstein CN, Warrington RJ, Ma Y and Peng Z. The role and potential therapeutic appli-cation of myeloid-derived suppressor cells in TNBS-induced colitis. J Leukoc Biol 2013; 94: 803-811.